Literature DB >> 22868444

Corneal endothelial loss after crosslinking with riboflavin and ultraviolet-A.

Clemens Lange1, Daniel Böhringer, Thomas Reinhard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22868444     DOI： 10.1007/s00417-012-2101-x

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  12 in total

1.  Endothelial cell loss associated with diffuse lamellar keratitis because of laser-assisted in situ keratomileusis.

Authors:  Prashaant Chaudhry; Gaurav Prakash; Amar Agarwal; Anjum Iqbal Mazhari; Dhivya Ashok Kumar; Athiya Agarwal; Soosan Jacob
Journal:  Eye Contact Lens       Date:  2012-07       Impact factor: 2.018

2.  Collagen crosslinking with ultraviolet-A and hypoosmolar riboflavin solution in thin corneas.

Authors:  Farhad Hafezi; Michael Mrochen; Hans Peter Iseli; Theo Seiler
Journal:  J Cataract Refract Surg       Date:  2009-04       Impact factor: 3.351

3.  Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: long-term results.

Authors:  Frederik Raiskup-Wolf; Anne Hoyer; Eberhard Spoerl; Lutz E Pillunat
Journal:  J Cataract Refract Surg       Date:  2008-05       Impact factor: 3.351

4.  Transient corneal thinning in eyes undergoing corneal cross-linking.

Authors:  Juha M Holopainen; Kari Krootila
Journal:  Am J Ophthalmol       Date:  2011-07-02       Impact factor: 5.258

5.  Prognostic factors for the progression of keratoconus.

Authors:  S J Tuft; L C Moodaley; W M Gregory; C R Davison; R J Buckley
Journal:  Ophthalmology       Date:  1994-03       Impact factor: 12.079

6.  Even after UVA-exposure will nitric oxide protect cells from reactive oxygen intermediate-mediated apoptosis and necrosis.

Authors:  C V Suschek; K Briviba; D Bruch-Gerharz; H Sies; K D Kröncke; V Kolb-Bachofen
Journal:  Cell Death Differ       Date:  2001-05       Impact factor: 15.828

Review 7.  Crosslinking treatment of progressive keratoconus: new hope.

Authors:  Gregor Wollensak
Journal:  Curr Opin Ophthalmol       Date:  2006-08       Impact factor: 3.761

8.  Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus.

Authors:  Gregor Wollensak; Eberhard Spoerl; Theo Seiler
Journal:  Am J Ophthalmol       Date:  2003-05       Impact factor: 5.258

9.  Keratitis and corneal scarring after UVA/riboflavin cross-linking for keratoconus.

Authors:  Carina Koppen; Jérôme C Vryghem; Laure Gobin; Marie-José Tassignon
Journal:  J Refract Surg       Date:  2009-09-11       Impact factor: 3.573

10.  Corneal cross-linking and safety issues.

Authors:  Eberhard Spoerl; Anne Hoyer; Lutz E Pillunat; Frederik Raiskup
Journal:  Open Ophthalmol J       Date:  2011-02-11
View more
  4 in total

Review 1.  [Riboflavin UVA crosslinking in progressive keratoconus].

Authors:  P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

2.  [Riboflavin UVA cross-linking for keratoconus].

Authors:  P Maier; T Reinhard
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

3.  Prospective, randomized, double-blind trial to investigate the efficacy and safety of corneal cross-linking to halt the progression of keratoconus.

Authors:  Stefan J Lang; Elisabeth M Messmer; Gerd Geerling; Marc J Mackert; Tobias Brunner; Sylvia Dollak; Borislav Kutchoukov; Daniel Böhringer; Thomas Reinhard; Philip Maier
Journal:  BMC Ophthalmol       Date:  2015-07-21       Impact factor: 2.209

4.  Corneal endothelial damage after simultaneous PRK and corneal cross-linking in stable keratoconus.

Authors:  Sebastiano Serrao; Marco Lombardo
Journal:  Am J Ophthalmol Case Rep       Date:  2019-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.